BAX
$36.65
Baxter International
($.26)
(.70%)
BAX
Earnings Whisper ®
N/A
3rd Quarter September 2024
Consensus:  $0.78
Revenue:  $3.84 Bil
Thursday
Oct 31
7:15 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Tuesday, August 6, 2024

What do you expect when BAX reports earnings?
Beat
Meet
Miss

Where is BAX's stock price going from here?
Up
Flat
Down
Stock chart of BAX
Analysts
Summary of analysts' recommendations for BAX
Score
Grade
Pivots
Resistance
$38.21
$37.88
$37.26

$36.93

Support
$36.31
$35.98
$35.36
Tweet
Growth
Description
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Peers
Boston ScientificStrykerAbbottBecton, DickinsonWaters3MTeleflexResMedIntegra LifeSciences HoldingsMerit Medical Systems